Ultragenyx Pharmaceutical shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.0M | 42k | 47.82 |
| 2023-09-30 | $2.2M | 61k | 35.65 |
| 2023-06-30 | $1.9M | 42k | 46.13 |
| 2022-12-31 | $488k | 11k | 46.33 |
| 2022-09-30 | $333k | 8.0k | 41.39 |
| 2022-06-30 | $678k | 11k | 59.74 |
| 2022-03-31 | $457k | 5.5k | 83.33 |
| 2021-12-31 | $285k | 3.4k | 85.11 |
| 2021-09-30 | $499k | 5.5k | 89.97 |
| 2021-06-30 | $5.6M | 57k | 97.56 |
| 2021-03-31 | $8.4M | 74k | 113.85 |
| 2020-12-31 | $12M | 85k | 138.45 |
| 2020-09-30 | $3.4M | 41k | 82.18 |
| 2020-06-30 | $4.6M | 59k | 78.20 |
| 2020-03-31 | $1.6M | 35k | 44.53 |
| 2019-12-31 | $2.2M | 51k | 42.72 |
| 2019-09-30 | $1.6M | 39k | 42.69 |
| 2019-06-30 | $9.9M | 156k | 63.60 |
| 2019-03-31 | $5.6M | 81k | 69.33 |
| 2018-12-31 | $1.1M | 26k | 43.49 |
| 2018-09-30 | $1.8M | 24k | 76.34 |
| 2018-06-30 | $1.7M | 23k | 76.87 |
| 2018-03-31 | $1.2M | 24k | 51.00 |
| 2017-12-31 | $1.1M | 23k | 46.36 |
| 2017-06-30 | $16M | 261k | 62.11 |
| 2017-03-31 | $38M | 562k | 67.78 |
| 2016-12-31 | $54M | 765k | 70.31 |
| 2016-09-30 | $52M | 736k | 70.94 |
| 2016-06-30 | $66M | 1.3M | 48.91 |
| 2016-03-31 | $110M | 1.7M | 63.31 |
| 2015-12-31 | $199M | 1.8M | 112.18 |
| 2015-09-30 | $150M | 1.6M | 96.31 |
| 2015-03-31 | $681k | 11k | 61.35 |
| 2014-12-31 | $95k | 2.2k | 43.08 |
| 2014-06-30 | $37k | 834 | 44.40 |
| 2014-03-31 | $21k | 426 | 49.30 |